Human CEA ELISA Kit has been used to compare the analytical results of paper-based analytical device (PAD)-based sensing platform with commercial enzyme linked immunosorbent asay (ELISA) kits for measuring target carcinoembryonic antigen (CEA) levels. It has also been used to comparatively study the limit of detection (LOD) of the quartz crystal microbalance (QCM) immunosensing method.
